Phase I combination of sorafenib and erlotinib therapy in solid tumors: safety, pharmacokinetic, and pharmacodynamic evaluation from an expansion cohort.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples